Form 4: Maravai LifeSciences Director Constantine Mihas Reports Acquisition of Restricted Stock Units

Sentiment:

SEC Form 4 Filing


Director Constantine Mihas reports acquiring 20,645 restricted stock units of Maravai LifeSciences Holdings, Inc.

Summary

  • On May 23, 2024, Constantine Mihas, a director of Maravai LifeSciences Holdings, Inc., acquired 20,645 shares of Class A Common Stock.
  • These shares were in the form of restricted stock units granted at a price of $10.78 per share.
  • The restricted stock units vest in full upon the earlier of one year from the grant date or the date of the 2025 annual meeting of stockholders.
  • Following the transaction, Mihas beneficially owns 48,916 shares, which are held for the benefit of a GTCR-affiliated entity.
  • Mihas disclaims any pecuniary interest in these securities, and the report should not be deemed an admission of beneficial ownership for Section 16 purposes.

Sentiment

Score: 6

Explanation: Neutral sentiment as it's a standard disclosure of stock unit acquisition. The director's acquisition could be interpreted as a positive signal, but it's also part of a compensation package.

Positives

  • The acquisition of restricted stock units by a director could be seen as a positive sign, indicating confidence in the company's future performance.

Future Outlook

The restricted stock units vest in full upon the earlier of one year from the date of grant or the date of the 2025 Maravai LifeSciences Holdings, Inc. annual meeting of stockholders.

Management Comments

  • The Reporting Person holds these securities of the Issuer for the benefit of a GTCR-affiliated entity.
  • The Reporting Person disclaims any pecuniary interest in the securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16.

Industry Context

Form 4 filings are routine disclosures required by the SEC to ensure transparency in insider trading activities, providing investors with insights into the actions of company directors and officers.

Stakeholder Impact

  • The acquisition of shares by a director can influence investor sentiment and potentially impact the stock price.

Key Dates

DateDescription
05/23/2024Date of transaction: Acquisition of restricted stock units.
05/24/2024Date of report filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.